Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179022-19-000025)

Filing Details

Accession Number:: 0001179022-19-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-11 16:23:30
Reporting Period:: 2019-02-08

Accepted Time:: 2019-02-11 16:23:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522478	D Kevin Freeman	C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Ste 240 Norcross GA 30071		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-08	1,500	$4.29	1,500	No	4	P	Indirect	By a limited liability company wholly-owned by Freeman Global Holdings, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By a limited liability company wholly-owned by Freeman Global Holdings, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	22,043	Direct
Common Stock	16,000	Indirect	IRA

Footnotes

Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.